Sage Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Sage Therapeutics, Inc.‘s stocks are currently a part of 193 hedge funds’ portfolios, which represents 84.24% of the total amount of its stocks outstanding. This makes up a total of 49.42M shares of Sage Therapeutics, Inc.. Compared to the previous quarter, the number fell by -0.85% or -422.30K shares fewer. As for the holding position changes, 33.68% (65) of current hedge fund investors increased the number of shares held, 35.23% (68) of current holders sold a part of the shares held, and 18.65% (36) closed the holdings completely. 31 hedge funds are new holders of Sage Therapeutics, Inc. stock in Q1 2022, it is 16.06% of total holders.
Hedge funds holding Sage Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 188 |
|---|---|
| Q3 2017 | 171 |
| Q4 2017 | 225 |
| Q1 2018 | 250 |
| Q2 2018 | 268 |
| Q3 2018 | 274 |
| Q4 2018 | 244 |
| Q1 2019 | 261 |
| Q2 2019 | 266 |
| Q3 2019 | 280 |
| Q4 2019 | 255 |
| Q1 2020 | 219 |
| Q2 2020 | 209 |
| Q3 2020 | 224 |
| Q4 2020 | 244 |
| Q1 2021 | 255 |
| Q2 2021 | 250 |
| Q3 2021 | 215 |
| Q4 2021 | 202 |
| Q1 2022 | 193 |
Hedge funds changes in Sage Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 26 | 61 | 73 | 23 | 5 |
|---|---|---|---|---|---|
| Q3 2017 | 24 | 72 | 52 | 37 | -14 |
| Q4 2017 | 82 | 73 | 62 | 28 | -20 |
| Q1 2018 | 56 | 105 | 66 | 28 | -5 |
| Q2 2018 | 46 | 114 | 78 | 27 | 3 |
| Q3 2018 | 42 | 95 | 91 | 33 | 13 |
| Q4 2018 | 29 | 91 | 87 | 59 | -22 |
| Q1 2019 | 52 | 130 | 59 | 34 | -14 |
| Q2 2019 | 46 | 97 | 82 | 34 | 7 |
| Q3 2019 | 44 | 99 | 93 | 30 | 14 |
| Q4 2019 | 58 | 103 | 65 | 75 | -46 |
| Q1 2020 | 49 | 78 | 64 | 83 | -55 |
| Q2 2020 | 46 | 81 | 53 | 55 | -26 |
| Q3 2020 | 40 | 70 | 75 | 25 | 14 |
| Q4 2020 | 51 | 70 | 85 | 30 | 8 |
| Q1 2021 | 53 | 77 | 86 | 42 | -3 |
| Q2 2021 | 43 | 96 | 72 | 46 | -7 |
| Q3 2021 | 30 | 89 | 64 | 60 | -28 |
| Q4 2021 | 23 | 73 | 72 | 35 | -1 |
| Q1 2022 | 31 | 65 | 68 | 36 | -7 |
Hedge funds changes in Sage Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 162,877,000 | 138,120,000 |
|---|---|---|
| Q3 2017 | 66,511,000 | 109,237,000 |
| Q4 2017 | 302,938,000 | 264,116,000 |
| Q1 2018 | 62,099,000 | 52,582,000 |
| Q2 2018 | 61,145,000 | 57,979,000 |
| Q3 2018 | 63,141,000 | 9,062,112,000 |
| Q4 2018 | 129,433,000 | 93,592,000 |
| Q1 2019 | 177,226,000 | 98,924,000 |
| Q2 2019 | 103,155,000 | 161,656,000 |
| Q3 2019 | 102,319,000 | 123,968,000 |
| Q4 2019 | 139,083,000 | 99,424,000 |
| Q1 2020 | 14,769,000 | 13,760,000 |
| Q2 2020 | 30,473,646 | 21,937,000 |
| Q3 2020 | 59,587,000 | 27,021,000 |
| Q4 2020 | 54,796,000 | 46,628,000 |
| Q1 2021 | 48,677,000 | 96,169,000 |
| Q2 2021 | 59,102,000 | 125,076,000 |
| Q3 2021 | 15,421,000 | 34,517,000 |
| Q4 2021 | 53,231,000 | 32,380,000 |
| Q1 2022 | 26,786,000 | 23,577,000 |